Medicaid Pharmaceutical Pricing Transgender Rights Affordable Care Act Drug Pricing Insurance Regulation LGBTQ+ Rights Medicare Drug Pricing Policy Reproductive Health NHS Funding Prescription Drug Pricing Pharmaceutical Regulation Pharmaceutical Policy Health Insurance Pharmaceutical Regulations Medicaid Funding Immigration Policy Public Health Initiatives Public Health Medicaid Cuts Abortion Legislation Medicaid Reform Legislation Health Insurance Reform Social Welfare Subsidies Reproductive Health Policy Labor Relations Education Policy Nursing Care Insurance Medicaid Expansion Reproductive Rights Reform Proposals Medicare and Medicaid NHS Reforms International Cooperation Insurance Coverage Abortion Rights NHS Management Abortion Policy Patient Rights Health Reform Family Planning Women's Health Policy NHS Services Aide Médicale d'État Infrastructure Policy Medicare Reform Pharmacy Regulations NHS Regulations Medical Training NHS Reform International Relations Medical Education Tax Policy Nursing Regulations Medicare Expansion Economic Policy Social Security Labor Policy Digital Health Initiatives Obamacare Drug Affordability Hospital Reform Addiction Treatment Healthcare Reform Privatization Sick Leave Regulations Child Welfare Immigration Healthcare Transgender Issues Medicaid Reforms Economic Measures Regulatory Changes Veterans Affairs Crisis Response Women's Health Local Government Insolvency Law Patient Fines California Healthcare Legislation Pharmaceutical Benefits Scheme Executive Orders Health Minister Statements Research Funding Research Funding Policy Affordability In-Vitro Fertilization Funding for Nursing Homes Funding Physician Retention Education Reform Legislative Actions Euthanasia Legislation Regulatory Oversight Regulation of Healthcare Social Equity Incentives Child Welfare Policy
By tying Medicare and Medicaid participation to hospitals’ policies for minors, the administration triggers a rulemaking that opponents vow to challenge in court.